Scientific Need

Flexible and powerful solutions designed to solve research challenges specific to scientific disciplines and processes or industry.

Scientific Need

Share

Bioinformatics

Bioinformatics is at the heart of many areas of modern biology and offers great opportunity for scientific advancement, particularly in systems biology and personalized medicine.  The applications are numerous: biomarker analysis, drug discovery, toxicology, health and wellness, disease diagnosis and monitoring, food safety, and counter-bioterrorism.  However, the enormous volume of disparate data that must be analyzed, along with the frequent availability of new analysis techniques, presents a data management and analysis challenge that can threaten project success. 

Accelrys’ software for bioinformatics enable you to:

  • Easily access and manage scientific data scattered across your organization
  • Access datasets from past experiments reducing unnecessary re-testing
  • Leverage experience of lead bioinformaticians by sharing best practices across the organization

Related Products and Solutions

Pipeline Pilot

Increase the efficiency of your bioinformatics workflows through the collection, mining, analysis and sharing of data across the organization with Pipeline Pilot and the Pipeline Pilot Biology Collections.

Learn more about Accelrys bioinformatics solutions:

Accelrys Biological Registration System

Streamline your processes and protect your IP with the market's first multi-entity, fully-integrated system for registering, relationship-tracking, querying, and reporting on complex biological entities. Built in close collaboration with top pharmaceutical companies, this award-winning system has the power and flexibility needed to integrate within existing infrastructures and adapt to your organization's changing needs.


Learn more about the Accelrys Biological Registration System

Browse By:

How does your company measure up? take the free maturity model assessment and start realizing faster,repeatable results from r and d investments.